Matthew Maxwell Donley
CIK 1636642 · Chief Operating Officer · last filed 2026-03-03
Matthew Maxwell Donley is a Chief Operating Officer who has filed 24 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for AUPH, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.76M
2
24
-$1.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Chief Operating Officer | 680,299 | $15.82 | $10.76M | -$1.11M | 10 | 2026-03-03 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | EVP, Global HR, IT & Strategy | 36,975 | — | — | $0 | 14 | 2018-02-13 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | AUPH | Mixed | +17,399 | -$579.2K | EDGAR |
| 2026-02-23 | AUPH | Tax (F) | −32,901 | -$473.8K | EDGAR |
| 2026-01-05 | AUPH | Mixed | +11,379 | -$682.5K | EDGAR |
| 2025-03-04 | AUPH | Mixed | +93,455 | -$994.4K | EDGAR |
| 2024-03-07 | AUPH | Sell (S) | −40,665 | -$224.1K | EDGAR |
| 2024-02-22 | AUPH | Grant (A) | +216,666 | $0 | EDGAR |
| 2023-03-06 | AUPH | Grant (A) | +271,134 | $0 | EDGAR |
| 2022-11-23 | AUPH | Buy (P) | +10,000 | $46.6K | EDGAR |
| 2022-03-04 | AUPH | Mixed | +5,448 | -$36.7K | EDGAR |
| 2021-05-12 | AUPH | Buy (P) | +9,900 | $99.7K | EDGAR |